Vancouver, BC – July 27, 2017: North Road Ventures, a wholly-owned subsidiary of Liberty Leaf Holdings Ltd. (CSE: LIB, OTCQB: LIBFF and FSE: HN3P) (the “Company” or “Liberty Leaf”) has received notification from Health Canada’s Office of Medical Cannabis that its ACMPR application has advanced to the Detailed Review Stage.
The progression to the Detailed Review Stage means that North Road’s application to be an ACMPR-approved licensed producer is now closer than ever.
Acquired by Liberty Leaf on October 19, 2016, North Road Ventures (an Access to Cannabis for Medical Purposes Regulations applicant) focuses on distributing high-quality medical cannabis. The company is expanding into the recreational market to coincide with the anticipated legalization in 2018.
The application had been submitted on North Road’s behalf by Cannabis Compliance Inc., an industry leader on such matters.
“Achieving a license requires a broad set of expertise,” explained Brian Wagner, CEO of Cannabis Compliance Inc. “Since 2013, our experienced team has lived and breathed commercial cannabis operations in Canada, advising on everything from genetics sourcing, cultivation, security and facility design, to quality assurance, regulatory licensing and business planning.”
In addition, David Hyde & Associates, an established security consulting firm in the cannabis industry, has designed and developed the security sections for North Road’s application.
“We are thrilled to have both of these exceptional firms working on our behalf. Based on this exciting development, we are extremely confident that our application is well on its way to being approved,” said Will Rascan President and CEO of Liberty Leaf.
North Road anticipating – and ready for – licensing under ACMPR
Health Canada recently arranged a conference call with North Road’s management team. Two senior managers from Health Canada’s Office of Medical Cannabis reviewed the progress of North Road’s application and explained their detailed review process. This phone call was followed by correspondence that reads in part: “Once both the review and the security clearance processes are completed, [North Road Ventures] will be advised and will be sent a Confirmation of Readiness Letter to determine their readiness for licensing under the ACMPR.”
About Liberty Leaf
Liberty Leaf Holdings Ltd. is a new Canadian-based, public company whose focus is to build and support a diversified portfolio of cannabis sector businesses, including cultivation, value added CBD/THC products, biotech research, and supply chain products within this dynamic and fast growing sector.
Liberty Leaf also owns 100% of North Road Ventures –– a late-stage applicant under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR).
On Behalf of the Board
Will Rascan, President & CEO
Liberty Leaf Holdings Ltd.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward looking statements. The company disclaims any intention or obligation to revise or update such statements.